The juvenile laryngeal papillomatosis is the most frequent benign tumour of multiple laryngeal papillomatosis larynx. In Sir Multiple laryngeal papillomatosis MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term multiple laryngeal papillomatosis juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract the most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is a disease helminthic immunity frequent between 3 and 5 years, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa. The annual costs of the treatment of this disease are over million USD.
multiple laryngeal papillomatosis The evolution of the disease decreases the quality of the life of the patient multiple laryngeal papillomatosis malignancy and death can occur during the disease. Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists. Multiple laryngeal papillomatosis evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment.
Material and method: using data from the literature of specialty and the clinical experience in the ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the multiple laryngeal papillomatosis in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.